WHO says it has been identified in Burundi, Kenya, Rwanda and Uganda – all countries that have never reported cases of mpox before. The public health emergency was declared by the group’s ...

As a deadly mpox outbreak continues to spread in Africa and other parts of the world, questions are emerging about whether some vulnerable people in the United States may need booster doses of the ...

Mpox (formerly known as monkeypox) is back in the news. As of early September, the World Health Organization has reported more than 5,000 laboratory-confirmed cases this year. Given the well ...

Mpox is now considered a global health emergency as cases surge in Central Africa and a new, more severe subtype of the virus spreads to multiple countries — prompting concerns about lockdowns ...

Johannesburg — Health officials in the Democratic Republic of Congo said Thursday they would start administering mpox vaccinations on Oct. 2, about a week sooner than initially planned ...

Canada, France, Germany, Spain, and the U.S. have promised to donate mpox vaccines from their own stores to African nations which are currently battling an outbreak of the disease. The World ...

Mpox, an infectious disease caused by the Mpox virus, has recently received international attention due to an increase in cases and the possible impact on public health. The disease was initially ...

Last month, the World Health Organization announced yet another emergency of international concern: Mpox. The declaration followed a steady increase in cases–over 30,000 and climbing–that ...

The Centre today said that an mpox case involving a man in Kerala was from the fast-spreading clade 1b variety, marking South Asia's first recorded case from the new strain. India has reported its ...

Authorities in the Democratic Republic of Congo said that 50,000 doses of mpox vaccine from the United States arrived in the country on Tuesday, a week after the first batch arrived from the ...

Tonix Pharmaceuticals shares jumped 38% after presenting data on TNX-801, a potential single-dose mpox vaccine. Preclinical studies suggest it could block transmission and offer improved protection.